Our Services
Our Company
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut feugiat urna arcu. Mauris lobortis nulla ut aliquet interdum.
Mauris lobortis nulla ut aliquet interdum. Donec commodo ac elit sed placerat. Mauris rhoncus est ac sodales gravida. In eros felis, elementum aliquam nisi vel, pellentesque faucibus nulla. Lorem ipsum dolor. View More
Our Team
BRUNO DOE
CEO
JEFF DOE
Developer
JESSICA DOE
Marketing
GREG DOE
SEO
ALEX DOE
Support
MELISSA DOE
Support
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec hendrerit vehicula est, in consequat. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec hendrerit vehicula est, in consequat. Donec hendrerit vehicula est, in consequat. Donec hendrerit vehicula est, in consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec hendrerit vehicula est, in consequat. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec hendrerit vehicula est, in consequat.
Our Blog
Provider Alert! Change in Preferred Drug List Status for Glucocorticoids, Inhaled Drug Class
Date: December 8, 2023 Attention: Providers Effective date: December 15, 2023 Call to action: Effective December 15, 2023, the Texas Health and Human... read more
Provider Alert! Important Dates: Complete EVV Visit Maintenance and Submit VMURs Before Losing Access
Date: December 8, 2023 Attention: STAR Kids Providers/Consumer Directed Services employers and FMSA Providers Call to action: Texas Children’s Health Plan (TCHP)... read more
Provider Alert! Follow-Up Care for Children Prescribed ADHD Medication (ADD, ADD-E)
Date: December 7, 2023 Attention: All Providers Call to Action: Texas Children Health Plan (TCHP) would like to remind providers to continue to... read more
Provider Alert! Coverage of Vyjuvek (procedure code J3401) Begins January 2024; Prior Authorization Effective February 2024
Date: December 6, 2023 Attention: All Providers Prior Authorization Effective Date: February 1, 2024 Call to action: Texas Children’s Health Plan (TCHP) would... read more
